title: Impairment of B cell receptor-mediated Ca2+ influx, activation of mitogen-activated protein kinases and growth inhibition in CD72-deficient BAL-17 cells.
abstract: CD72 is a 45 kDa B cell-specific type II transmembrane protein of the C-type lectin superfamily. It was originally defined as a receptor-like molecule that regulates B cell activation and differentiation; however, its precise function remains unclear since more recent functional analyses, including a gene targeting study, suggest that CD72 may serve as a negative or a positive regulator of B cell signaling. In the present study, we analyzed the cell-autonomous function of CD72 in B cell receptor (BCR) signaling using CD72-deficient cells generated from mature BAL-17 cells. We found that BCR-mediated phosphorylation of CD19, Btk, Vav and phospholipase Cgamma2 and association of CD19 with phosphatidylinositol-3 kinase were impaired in CD72-deficient cells. Inositol trisphosphate synthesis was normally induced initially but ablated at 1 min of stimulation in CD72-deficient cells. In the event, Ca(2+) release from intracellular stores remained intact, though influx of extracellular Ca(2+) was severely impaired in CD72-deficient cells. Furthermore, BCR-evoked activation of mitogen-activated protein kinases (MAPKs), extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase, and growth inhibition in BAL-17 cells were blocked in the absence of CD72. Significantly, these effects were largely reversed by re-expression of CD72. Thus, CD72 appears to exert a positive effect on BCR signaling pathways leading to Ca(2+) influx and MAPK activation, which in turn may determine the fate of BAL-17 cells.
authors.affiliation: Department of Immunology and Signal Transduction, Tokyo Metropolitan Institute for Neuroscience, Tokyo Metropolitan Organization for Medical Research, Fuchu, Tokyo 183-8526, Japan.
authors.forename: Mami
authors.initials: M
authors.lastname: Ogimoto
authors.forename: Gaku
authors.initials: G
authors.lastname: Ichinowatari
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Watanabe
authors.forename: Nobuhiko
authors.initials: N
authors.lastname: Tada
authors.forename: Kazuya
authors.initials: K
authors.lastname: Mizuno
authors.forename: Hidetaka
authors.initials: H
authors.lastname: Yakura
mesh_terms: D000818:Animals; D020013:Calcium Signaling / Q000276:immunology*; D018797:Cell Cycle Proteins / Q000378:metabolism; D048708:Cell Growth Processes / Q000276:immunology*; D002460:Cell Line; D037181:Lectins, C-Type / Q000276:immunology*; D051379:Mice; D020928:Mitogen-Activated Protein Kinases / Q000276:immunology*; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D051567:Proto-Oncogene Proteins c-vav; D011947:Receptors, Antigen, B-Cell / Q000172:deficiency* / Q000276:immunology*
chemical_list: D018797:Cell Cycle Proteins; D037181:Lectins, C-Type; D011518:Proto-Oncogene Proteins; D051567:Proto-Oncogene Proteins c-vav; D011947:Receptors, Antigen, B-Cell; C496619:Vav1 protein, mouse; D020928:Mitogen-Activated Protein Kinases